Corporate - Media & Press
Dr. Schena’s Microarray Analysis Textbook Tops Amazon.com Sales.
Sunnyvale, CA, March 1, 2004 – Arrayit announced that Microarray Analysis, a textbook written by the company’s Visiting Scholar Dr. Mark Schena, has risen to the top of the Amazon.com sales ranking for all microarray books. Microarray Analysis is published by J. Wiley & Sons and currently holds the top position on Amazon, moving as high as position 5,000 for all books sold on the Amazon.com site.
Dr. Schena seemed pleased by the finding. “The microarray field has grown very rapidly over the years, to the point where there are dozens of microarray books on the Amazon site. To have Microarray Analysis hold the top position is an honor, particularly given the quality of the other books and the competition in the field. The publisher and I worked very hard to assemble a textbook that would be embraced by a wide readership. Judging by the number one ranking of Microarray Analysis as well as the strong sales of some of the microarray reference books, particularly in the bioinformatics area, suggests that instructors are using Microarray Analysis as the main course text and supplementing MA with specialty books to expand critical areas. Our goal was to provide a solid foundational text in a new science area, and then to work with other authors to supplement special topics. The Amazon.com sales numbers seem to suggest this is happening, which was our goal when we started the project in 2001. To see Microarray Analysis selling better that some of the famous science textbooks out there is a personal thrill for me because many of those authors were my teachers.”
TeleChem International is a privately owned high-tech company located in the heart of California’s Silicon Valley. Our products and services are provided by three corporate divisions: ArrayIt® Life Sciences Division, Chemicals Division, and a Diagnostics Division. The ArrayIt® Life Sciences Division offers a complete microarray technology platform that empowers >10,000 laboratories to use microarrays for human genome exploration, basic research, drug discovery, and myriad life sciences applications. Nearly every major research institution uses our patented microarray manufacturing technology (U.S. 6,101,946) and supporting products and services. The Chemicals Division provides import and export services and government contract manufacturing in the area of industrial chemicals for plastics, fire control, water treatment, agriculture, industrial and institutional compounding, and green energy. The Diagnostics Division holds key patents in the United States (6,913,879), Singapore (94899), New Zealand (523560), and other countries for its revolutionary “multi-patient” genotyping technology, which allows as many as 100,000 patients to be tested on a single microarray. Arrayit Diagnostics enables genotyping and disease diagnostics by providing testing kits, services, and technology transfer opportunities for disease screening and testing organizations.
Copyright 1993-2013 Arrayit Corporation. All rights reserved.